Search results (6)
« Back to PublicationsImplications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer.
Journal article
Javed SR. et al, (2024), Br J Cancer, 131, 1724 - 1736
Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic.
Journal article
Skolariki A. et al, (2022), Explor Target Antitumor Ther, 3, 172 - 199
NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)
Conference paper
Coveler A. et al, (2022), ANNALS OF ONCOLOGY, 33, S697 - S698
NUC-7738 in patients with advanced solid tumours: Phase I results from the NuTide:701 phase I/II study
Conference paper
Symeonides SN. et al, (2022), ANNALS OF ONCOLOGY, 33, S745 - S746
PHASE 1 STUDY OF THE PORCUPINE (PORCN) INHIBITOR RXC004 IN COMBINATION WITH THE PD-1 INHIBITOR NIVOLUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
Conference paper
Cook N. et al, (2022), JOURNAL FOR IMMUNOTHERAPY OF CANCER, 10, A752 - A752
The evolving role of PARP inhibitors in advanced ovarian cancer
Journal article
Levva S. et al, (2021), Forum of Clinical Oncology, 12, 82 - 104